Status:
COMPLETED
Resiliency Training on the College Campus
Lead Sponsor:
Massachusetts General Hospital
Conditions:
Psychotic Disorders
Mood Disorders
Eligibility:
All Genders
18-30 years
Phase:
NA
Brief Summary
This is a waitlist controlled study examining the initial efficacy of Resilience Training among college students at an elevated risk for a severe mental illness.
Eligibility Criteria
Inclusion
- 18-30 years old
- Enrolled in undergraduate program at the college or university where the intervention takes place
- Students who endorse delusion-like experiences (DLEs): Peter's et al. Delusion Inventory (PDI) score \> 4 and/or
- Students with mild to moderate depressive symptoms: Beck Depression Inventory (BDI) score ≥ 6
Exclusion
- Inability to provide informed consent
- Not proficient in English
- Current self-reported Diagnostic Statistical Manual 5 (DSM-5) diagnosis with active symptoms (such as active psychotic symptoms, current suicidality, serious active alcohol or substance use, marked deterioration in functioning over the prior month) determined by clinical interview with participant, or self-report of a psychiatric diagnosis that necessitates close monitoring or individual therapy and/or inpatient or partial hospitalization
- Current enrollment in psychological or behavioral health treatment.
- Current use of psychotropic medications (other than stimulants) prescribed by a physician.
Key Trial Info
Start Date :
July 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2020
Estimated Enrollment :
107 Patients enrolled
Trial Details
Trial ID
NCT06038786
Start Date
July 1 2018
End Date
March 1 2020
Last Update
September 15 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Massachusetts General Hospital
Charlestown, Massachusetts, United States, 02129